Endothelial dysfunction appears to be an integral aspect of the insulin res
istance syndrome, independently of hyperglycemia. The ability of insulin to
cause endothelium-derived nitric oxide (NO)-dependent vasodilation amplifi
es its overall effect of stimulating skeletal muscle glucose uptake and mod
ulating vascular tone, The dose-dependent physiologic increase in skeletal
muscle blood flow in response to insulin, which is highly associated with t
he rate of glucose metabolism, is impaired in insulin-resistant states. Ins
ulin appears to mediate vasodilation by direct stimulation bf release of NO
from endothelium. Studies of the response to the endothelium-dependent vas
odilator methacholine chloride in lean and obese nondiabetic subjects and o
bese subjects with type 2 diabetes mellitus indicate that there may be mark
ed endothelial dysfunction very early in insulin resistance, The potent vas
oprotective effects of NO mitigate various atherogenic processes, including
vascular smooth muscle cell proliferation, platelet adhesion and thromboge
nesis, lipid peroxidation, and monocyte adhesion to endothelial cells. The
interaction between insulin and NO may contribute to the prominent outcomes
of insulin resistance syndrome (viz,, hypertension, thrombosis, and athero
sclerosis), (C) 1999 by Excerpta Medico, Inc.